Clinical Trial: NRG HN002

NRG HN002

Status: Closed

A Randomized Phase II Trial for Patients with p16 Positive, Non-Smoking Associated, Locoregionally Advanced Oropharyngeal Cancer

HN002 is closed  to accrual, effective February 7, 2017.